These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1913680

  • 1. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, Yokota J.
    Cancer Res; 1991 Oct 15; 51(20):5632-5. PubMed ID: 1913680
    [Abstract] [Full Text] [Related]

  • 2. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 3. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K.
    Cancer Res; 1992 Dec 01; 52(23):6588-93. PubMed ID: 1423304
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS.
    Cancer Res; 1994 Jan 15; 54(2):499-505. PubMed ID: 8275488
    [Abstract] [Full Text] [Related]

  • 5. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T.
    Cancer Res; 1993 Apr 15; 53(8):1883-8. PubMed ID: 8385572
    [Abstract] [Full Text] [Related]

  • 10. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, Iino H, Fukayama M, Koike M, Mori T.
    Cancer Res; 1992 Jul 15; 52(14):3965-71. PubMed ID: 1319835
    [Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS.
    Anticancer Res; 1996 Jul 15; 16(4A):2009-15. PubMed ID: 8712735
    [Abstract] [Full Text] [Related]

  • 12. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, Wada K, Nishisaki H, Konda Y, Nagao M.
    Cancer Res; 1992 Aug 15; 52(16):4335-41. PubMed ID: 1322785
    [Abstract] [Full Text] [Related]

  • 13. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 14. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.
    Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
    Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S.
    Cancer Res; 1992 Jun 01; 52(11):3099-102. PubMed ID: 1591722
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K, Sugano K, Fukayama N, Nakashima Y, Saotome K, Yokoyama T, Yokota T, Ohkura H.
    Am J Gastroenterol; 1997 Feb 01; 92(2):307-12. PubMed ID: 9040212
    [Abstract] [Full Text] [Related]

  • 20. p53 gene mutations in colorectal tumors from patients with familial polyposis coli.
    Shirasawa S, Urabe K, Yanagawa Y, Toshitani K, Iwama T, Sasazuki T.
    Cancer Res; 1991 Jun 01; 51(11):2874-8. PubMed ID: 1851662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.